United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 6, 2026 · Filed Apr 7, 2026

On Apr 6, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$558.41 for US$5.3M under a trading plan, leaving 40,513 shares. Filed Apr 7, 2026 (Form 4).

Sold
9,500 shares
Price
US$558.41 average (US$552.65 to US$566.00)
Value
US$5.3M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 6, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 6, 2026Common StockSale80US$552.6549,933Direct
Apr 6, 2026Common StockSale400US$553.9649,533Direct
Apr 6, 2026Common StockSale1,209US$555.2548,324Direct
Apr 6, 2026Common StockSale1,219US$556.1947,105Direct
Apr 6, 2026Common StockSale1,386US$557.2145,719Direct
Apr 6, 2026Common StockSale1,806US$558.3143,913Direct
Apr 6, 2026Common StockSale922US$559.4142,991Direct
Apr 6, 2026Common StockSale558US$560.1042,433Direct
Apr 6, 2026Common StockSale520US$561.5141,913Direct
Apr 6, 2026Common StockSale402US$562.5441,511Direct
Apr 6, 2026Common StockSale716US$563.3840,795Direct
Apr 6, 2026Common StockSale122US$564.2240,673Direct
Apr 6, 2026Common StockSale160US$566.0040,513Direct

Source

View original at SEC

Related